These additional results demonstrated that once-daily dosing with the enteric-coated tablet
formulation of RDEA806 resulted in significant reductions in plasma viral load that were consistent with results previously presented with twice-daily dosing of the capsule formulation in the same study.
, sustained-release or extended release coated capsules or tablets, sublingual and buccal tablets, and microencapsulated products should never be opened or crushed for administering through a feeding tube (3).
Examples are crushing of enteric-coated tablets
that protect the active ingredient against degradation by gastric acid, which would reduce bioavailability; and reduction of serum concentrations of phenytoin by 72% when it is administered with enteral feeds.
com and get a bottle of 120 enteric-coated tablets
seem to offer better protection, passing through the stomach intact and dissolving later.
5mg and 5mg enteric-coated tablets
in pots of 28 tablets.
protect the active ingredient against degradation by gastric acid, and crushing these tablets will reduce the bioavailability of the drug.
True (A) or false (B)--click on the correct answer: Enteric-coated tablets
protect the active ingredient against degradation by gastric acid.
Oral Belerofon is formulated as enteric-coated tablets
containing the lyophilized Belerofon protein.